Interesting to see the only approved covid treatment, Remdesivir currently will be a 5 day treatment and will cost us $2340 per treatment. This is based on us$390 per vial x 6 vials for recommended course of treatment.
it would be nice to get even a slice of that market, bearing in mind firstly that it was not our primary target, and secondly as soon as it was approved USA apparently tried to buy everything they could make for months ahead.
Again our biggest issue could just be scaling up production, assuming trials go well.
Royal Melb Hospital and Doherty Institute Associate Prof Steven Tong said re Remdesivir "My understanding is they're going to prioritize areas of the world where theres a lot of COVID at the moment, and that what will be provided to Australia will be fairly limeted-potentially only five hospitals- which doesnt cover much of our population"
let's hope our treatment can fill the gap asap.
- Forums
- ASX - By Stock
- RCE
- Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program, page-137
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online